OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies	428
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels	282
Is Oxytocin “Nature’s Medicine”?	215
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges	208
Rescuing the Last-Line Polymyxins: Achievements and Challenges	190
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development	171
Subcellular Organization of the cAMP Signaling Pathway	157
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function	148
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials	134
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms	118
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology	109
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics	102
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950	94
Sex- and Gender-Based Pharmacological Response to Drugs	93
Post-Translational Modifications of G Protein–Coupled Receptors Control Cellular Signaling Dynamics in Space and Time	92
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update	77
On the Clinical Pharmacology of Reactive Oxygen Species	75
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review	73
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?	73
Dopamine, Immunity, and Disease	71
Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches	71
Unlocking G-Quadruplexes as Antiviral Targets	67
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review	65
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species	64
Aldo-Keto Reductases and Cancer Drug Resistance	64

Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies	63
E1 Enzymes as Therapeutic Targets in Cancer	62
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications	59
Inhaled Medicines: Past, Present, and Future	52
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain	44
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning	43
Neurobiological Mechanisms of Nicotine Reward and Aversion	42
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors	42
Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease	41
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications	41
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development	40
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors	39
Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain	38